BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28732748)

  • 1. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
    Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
    J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
    Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
    J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
    Günther C; Blau K; Förster U; Viehweg A; Wozel G; Schäkel K
    Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
    Hänsel A; Günther C; Baran W; Bidier M; Lorenz HM; Schmitz M; Bachmann M; Döbel T; Enk AH; Schäkel K
    J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
    Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation.
    Günther C; Starke J; Zimmermann N; Schäkel K
    Clin Exp Dermatol; 2012 Mar; 37(2):169-76. PubMed ID: 22188261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis.
    Tahvili S; Zandieh B; Amirghofran Z
    Int J Dermatol; 2015 Jul; 54(7):e254-60. PubMed ID: 26108267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
    Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
    Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses.
    Hänsel A; Günther C; Ingwersen J; Starke J; Schmitz M; Bachmann M; Meurer M; Rieber EP; Schäkel K
    J Allergy Clin Immunol; 2011 Mar; 127(3):787-94.e1-9. PubMed ID: 21377044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling.
    Peng H; Guerau-de-Arellano M; Mehta VB; Yang Y; Huss DJ; Papenfuss TL; Lovett-Racke AE; Racke MK
    J Biol Chem; 2012 Aug; 287(33):28017-26. PubMed ID: 22733812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses.
    Gilles S; Jacoby D; Blume C; Mueller MJ; Jakob T; Behrendt H; Schaekel K; Traidl-Hoffmann C
    Clin Exp Allergy; 2010 Feb; 40(2):269-78. PubMed ID: 20210806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethylfumarate for psoriasis: more than a dietary curiosity.
    Mrowietz U; Asadullah K
    Trends Mol Med; 2005 Jan; 11(1):43-8. PubMed ID: 15649822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells.
    Wehner R; Wehrum D; Bornhäuser M; Zhao S; Schäkel K; Bachmann MP; Platzbecker U; Ehninger G; Rieber EP; Schmitz M
    Haematologica; 2009 Aug; 94(8):1151-6. PubMed ID: 19546436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid but not plasmacytoid blood DCs possess Th1 polarizing and Th1/Th17 recruiting capacity in psoriasis.
    Khasawneh A; Baráth S; Medgyesi B; Béke G; Dajnoki Z; Gáspár K; Jenei A; Pogácsás L; Pázmándi K; Gaál J; Bácsi A; Szegedi A; Kapitány A
    Immunol Lett; 2017 Sep; 189():109-113. PubMed ID: 28414181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].
    Döbel T; Schäkel K
    J Dtsch Dermatol Ges; 2014 Oct; 12(10):874-80. PubMed ID: 25262889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs).
    Bippes CC; Feldmann A; Stamova S; Cartellieri M; Schwarzer A; Wehner R; Schmitz M; Rieber EP; Zhao S; Schäkel K; Temme A; Scofield RH; Kurien BT; Bartsch H; Bachmann M
    PLoS One; 2011 Jan; 6(1):e16315. PubMed ID: 21283706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis.
    Brück J; Dringen R; Amasuno A; Pau-Charles I; Ghoreschi K
    Exp Dermatol; 2018 Jun; 27(6):611-624. PubMed ID: 29603404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-α.
    Tufa DM; Chatterjee D; Low HZ; Schmidt RE; Jacobs R
    Eur J Immunol; 2014 Dec; 44(12):3717-28. PubMed ID: 25229755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3.
    Costantini C; Calzetti F; Perbellini O; Micheletti A; Scarponi C; Lonardi S; Pelletier M; Schakel K; Pizzolo G; Facchetti F; Vermi W; Albanesi C; Cassatella MA
    Blood; 2011 Feb; 117(5):1677-86. PubMed ID: 21098395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells.
    Wehner R; Bitterlich A; Meyer N; Kloß A; Schäkel K; Bachmann M; Schmitz M
    Int J Cancer; 2013 Mar; 132(6):1351-9. PubMed ID: 22907335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.